Skip to main content

Comparative Evaluation of Drugs

  • Chapter
  • 94 Accesses

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 4))

Abstract

In most countries radiopharmaceutical drugs have now become recognized as substances which require reviewing and acceptance by a governmental agency before the medical profession is allowed their unrestricted use. However many uncertainties still exist about the basis for reviewing. Usually radiopharmaceuticals do not fit the concepts which apply to pharmaceuticals in general. Therefore it is often extremely unsatisfactory to apply the rules, developed for the evaluation of drugs to the process of evaluating a radioactive drug. In this presentation we will try to explore to what extent evaluation procedures accepted in the evaluation of pharmaceuticals may or may not be used in evaluating radiopharmaceuticals.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. General considerations for the clinical evaluation of drugs.1977 HEW (FDA) 77–3040.

    Google Scholar 

  2. Guidelines for the clinical evaluation of radiopharmaceutical drugs. 1981 HEW (FDA) 81–3120.

    Google Scholar 

  3. Legal and practical requirements for the registration of drugs. 1980, Zurich, I. F. P. M. A.

    Google Scholar 

  4. Feinstein AR. The architecture of clinical research. Clin Pharm Ther 1970;11: 432–41

    CAS  Google Scholar 

  5. Bell RS. Efficacy. What ’s that. Sem Nucl Med 1978; 8: 316–23

    Article  CAS  Google Scholar 

  6. Wagner HN. Bayes ’Theorem: an idea whose time has come? AmJ Cardiol 1982; 49: 875–77

    Article  PubMed  Google Scholar 

  7. Hamilton GN, Trobaugh GB, Ritchie JL et al. Myocardial imaging with Thallium-201: an analysis of clinical usefulness based on Bayes’ Theorem. Sem Nucl Med 1978; 8: 358–64

    Article  CAS  Google Scholar 

  8. Nosslin B. Quality control and data evaluation in nuclear medicine. Proc. 13th Int. Annual Meeting of the Soc. of Nucl. Med. Sept. 1975, Copenhagen. 307–15.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

de Jong, R., Huising, W.B. (1984). Comparative Evaluation of Drugs. In: Kristensen, K., Nørbygaard, E. (eds) Safety and efficacy of radiopharmaceuticals. Developments in Nuclear Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6753-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6753-3_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6755-7

  • Online ISBN: 978-94-009-6753-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics